Body temperature control in patients with refractory septic shock: too much may be harmful

Background The lowering of body temperature is a common, almost reflexive step in the daily care of septic shock patient. However, the effect of different magnitudes of fever control on the outcome of refractory septic patients with a very poor outcome is controversial and has yet to be explored. Methods This prospective trial examined sixty‐five refractory septic shock patients with a core temperature higher than 38.5°C. Patients were randomly assigned to a group achieving a “low temperature” range (LT group: 36.0‐37.5 °C) or to a group achieving a “high temperature” range (HT group: 37.5‐38.3 °C) by physical methods including a water‐flow cooling blanket and ice packs. A target core temperature was achieved in 1‐2 hours post‐treatment, and maintained for 72 hours. Averaged values of core temperature as well as hemodynamic, respiratory, and laboratory variables were analyzed at baseline and during the first 72 hours after fever control. Results Thirty‐four (52.31%) patients were assigned to the LT group and thirty‐one (47.69%) patients were assigned to the HT group. The mean core temperature was significantly lower in the LT group than in the HT group (36.61 vs. 37.85 °C, respectively; P < 0.0001). The average heart rate (HR) (75.5 vs. 91.9 beats/min, respectively; P < 0.0001) and the mean cardiac output (CO) (5.35 vs. 6.45 L/min, respectively; P = 0.002) were also statistically significant lower in the LT group than in the HT group. The averaged serum lactate level was significantly higher in the LT group compared to the HT group (5.59 vs. 2.82 mmol/L, respectively; P=0.008). Fibrinogen and activated partial thromboplatin time were also different between the two groups. The 28 days mortality was significantly higher in the LT group than in the HT group (61.8 vs. 25.8%, respectively; P=0.003). A Cox‐regression model analysis showed that mean core temperature during the 72 h period was an independent predictor of 28 days mortality (odds ratio (OR) = 0.42, 95%CI 0.25, 0.6; P=0.001). Conclusion Controlling fever to a lower range (36.0‐37.5 °C) may be harmful to patients with refractory septic shock by worsening tissue perfusion, compared to controlling it within a higher range (37.5‐38.3 °C). An understanding of the mechanisms responsible for these observations requires further investigation.

[1]  B. Cunha With sepsis: If fever is good, then hypothermia is bad! , 2012, Critical care medicine.

[2]  B. Souweine,et al.  Severe hypothermia increases the risk for intensive care unit-acquired infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Souweine,et al.  Determinants of temperature abnormalities and influence on outcome of critical illness* , 2012, Critical care medicine.

[4]  K. Ong,et al.  Hypothermia predicts mortality in critically ill elderly patients with sepsis , 2010, BMC geriatrics.

[5]  Joseph Varon,et al.  Therapeutic hypothermia: past, present, and future. , 2008, Chest.

[6]  John G. Bartlett,et al.  Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America , 2008, Critical care medicine.

[7]  D. Remick,et al.  Hypothermia and sepsis. , 2006, Frontiers in bioscience : a journal and virtual library.

[8]  C. Schulman,et al.  The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. , 2005, Surgical infections.

[9]  J. Vincent,et al.  FEVER CONTROL IN SEPTIC SHOCK: BENEFICIAL OR HARMFUL? , 2005, Shock.

[10]  H. Davies,et al.  Bloodstream Infection-Associated Sepsis and Septic Shock in Critically Ill Adults: A Population-Based Study , 2004, Infection.

[11]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[12]  D. Buggy,et al.  Thermoregulation, mild perioperative hypothermia and postanaesthetic shivering. , 2000, British journal of anaesthesia.

[13]  P. Marik Fever in the ICU. , 2000, Chest.

[14]  G. Bernard,et al.  Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. , 1999, Critical care medicine.

[15]  C. Manthous,et al.  Effect of cooling on oxygen consumption in febrile critically ill patients. , 1995, American journal of respiratory and critical care medicine.

[16]  R. Bone Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .

[17]  J. E. Carceller American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[18]  J. Macarthur,et al.  Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. , 1991, American journal of surgery.

[19]  M. McCarron,et al.  Septic Shock , 1964, International anesthesiology clinics.